Subtype
Blood Vessel Neoplasm
CI-CAN-00000567Explore in graph →
Non-malignant50 active trials4 approved drugs8 evidence items
- NCIt
- C7387
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000567Explore in graph →
Clinical trials
292 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06526897 | Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma | not yet recruiting | N/A | 1,582 | ECOG-ACRIN Cancer Research GroupNETWORK | 0 | Jul 30, 2024 | clinicaltrials |
| NCT00330564 | Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow | terminated | Phase 2 | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 27, 2024 |
| NCT03652181 | CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness | completed | — | 123 | University of ChicagoOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT04893018 | NT-I7 for Kaposi Sarcoma in Patients With or Without HIV | terminated | Phase 1 | 8 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT03316274 | Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma | completed | Early Phase 1 | 12 | University of California, San FranciscoOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT02029430 | A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma | completed | Phase 2 | 15 | ImmunityBio, Inc.INDUSTRY | 1 | Jun 11, 2024 | clinicaltrials |
| NCT05081141 | HHV8 and Solid Organ Transplantation | unknown | — | 250 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT00970970 | Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease(VHLimage) | completed | — | 22 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT03993106 | A Study of sEphB4-HSA in Kaposi Sarcoma | unknown | Phase 2 | 65 | Vasgene Therapeutics, IncINDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT00339937 | Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily | completed | — | 4,622 | National Cancer Institute (NCI)NIH | 1 | Mar 22, 2024 | clinicaltrials |
| NCT01764451 | Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins | terminated | Early Phase 1 | 12 | University of New MexicoOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT02913612 | Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)(TIM01) | completed | Phase 2 | 105 | Kanecia Obie ZimmermanOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT00019188 | Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2024 | clinicaltrials |
| NCT04336163 | Skin Imaging to Inform Laser Treatments | terminated | N/A | 55 | University of California, IrvineOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT03331744 | Clinical Characteristics of Infantile Hemangioma | unknown | — | 1,000 | West China HospitalOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT05324384 | Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma | unknown | Phase 2 | 30 | West China HospitalOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT05424016 | Propranolol and Von Hippel-Lindau Disease(PRO-HEB) | recruiting | N/A | 85 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT04518124 | Propranolol in Angiosarcoma | completed | Phase 2 | 14 | The Netherlands Cancer InstituteOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT02584309 | Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | 73 | Washington University School of MedicineOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT01873131 | A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn | recruiting | N/A | 126 | Massachusetts General HospitalOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT04020419 | Natural Berry Extract Treatment of Hemangiomas(Pediaberry) | terminated | Early Phase 1 | 12 | Gayle GordilloOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT03674346 | Efficacy of Hypnoanalgesia by a Radiologist Technologist in Children With Cutaneous Angioma Treated With Sclerosis in Interventional Radiology(HYP-ANGE) | unknown | N/A | 138 | Hospices Civils de LyonOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT05329792 | L19IL2/L19TNF in Skin Cancer Patients(IntriNSiC) | unknown | Phase 2 | 70 | Philogen S.p.A.INDUSTRY | 3 | Oct 6, 2023 | clinicaltrials |
| NCT03404297 | Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya | completed | N/A | 30 | Indiana UniversityOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT04448873 | Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma | completed | Phase 4 | 30 | Children's Hospital of Fudan UniversityOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT01685398 | Topical Timolol for Superficial Infantile Hemangioma | completed | Phase 3 | 48 | Mahidol UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02110069 | A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors | terminated | Phase 2 | 4 | Boston Children's HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05327309 | Role of Propranolol as Compared to Bleomycin in Management of Hemangioma | completed | N/A | 90 | Shaheed Zulfiqar Ali Bhutto Medical UniversityOTHER | 0 | Sep 13, 2023 | clinicaltrials |
| NCT01431326 | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care(PTN_POPS) | completed | — | 3,520 | Daniel BenjaminOTHER | 5 | Sep 6, 2023 | clinicaltrials |
| NCT03009201 | Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery | completed | Phase 1 | 16 | OHSU Knight Cancer InstituteOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT05961761 | Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients(PROPANE) | recruiting | Phase 2 | 80 | Niels JunkerOTHER | 3 | Jul 27, 2023 | clinicaltrials |
| NCT02120040 | Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System(PsychoVHL) | completed | N/A | 42 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT04293289 | Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma | completed | N/A | 10 | Cancer Intelligence Care Systems, Inc.INDUSTRY | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04077515 | Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma | completed | Phase 4 | 92 | Children's Hospital of Fudan UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
| NCT01495598 | Pomalidomide for Kaposi Sarcoma in People With or Without HIV | completed | Phase 1 / Phase 2 | 28 | National Cancer Institute (NCI)NIH | 1 | Nov 1, 2022 | clinicaltrials |
| NCT03921073 | Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma | terminated | Phase 2 | 5 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT00540566 | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | completed | — | 113 | University of California, IrvineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05515068 | Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas(COSS-Registry) | not yet recruiting | — | 1,000 | Klinikum StuttgartOTHER | 0 | Aug 25, 2022 | clinicaltrials |
| NCT01462630 | Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma | completed | Phase 2 | 29 | Fox Chase Cancer CenterOTHER | 1 | Aug 19, 2022 | clinicaltrials |
| NCT02342275 | Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma | completed | Phase 3 | 377 | West China HospitalOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT04065152 | Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma(KAPVEC) | unknown | Phase 2 | 20 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT01764360 | Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe(SIKO) | completed | N/A | 1,024 | University of Colorado, DenverOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT00346164 | Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma | completed | Phase 3 | 588 | Children's Oncology GroupNETWORK | 5 | Apr 28, 2022 | clinicaltrials |
| NCT02048722 | Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma | completed | Phase 2 | 31 | Northwestern UniversityOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT03188068 | Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma | completed | Phase 2 | 30 | West China HospitalOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT04836884 | Vascular Anomaly Pathology and Genomics Biopsy Study | completed | N/A | 3 | Mayo ClinicOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT02212015 | Evaluation of Votrient in Angiosarcoma(EVA) | terminated | Phase 2 | 26 | Heidelberg UniversityOTHER | 2 | Mar 22, 2022 | clinicaltrials |
| NCT01057121 | Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma | completed | Phase 1 / Phase 2 | 38 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2022 | clinicaltrials |
| NCT03296553 | Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. | completed | Phase 2 | 40 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 27, 2022 | clinicaltrials |
| NCT04607200 | AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma | withdrawn | Phase 2 | 0 | Agenus Inc.INDUSTRY | 0 | Jan 11, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Jul 30, 2024source: clinicaltrials